Selective COX-2 inhibitor. Active in vivo. IC50 (human chondrocytes) COX-1 = 36.6µM, COX-2 = 4.7µM
Product Details
| Formula: | C14H13N3O4S2 |
| |
| MW: | 351.4 |
| |
| CAS: | 71125-38-7 |
| |
| Purity: | ≥98% (UHPLC) |
| |
| Appearance: | Yellow solid. |
| |
| Solubility: | Soluble in DMSO (25mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | Ambient |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Understanding heterotopic ossification after spinal cord injury: I. Kulina; (2015), (PhD thesis),
Application(s): Injected subcutaneously in mice,
Full Text
Clinical experience with cyclooxygenase-2 inhibitors: J. van Ryn & M. Pairet ; Inflamm. Res.
48, 247 (1999),
Abstract;
Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes: F.J. Blanco, et al.; J. Rheumatol.
26, 1366 (1999),
Abstract;
